The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach
Dimitrios Papakonstantinou, Vasileios Vardas, Despoina M. Varouhaki, Aikaterini Kotzamouratoglou et autres
Objectives: Combretastatin A-4 (CA-4) is a microtubule-disrupting agent with established anti-tumor properties. This study aimed to evaluate the effects of CA-4 on key metastatic traits of cancer cells, including migration, clonogenic potential, cytoskeletal protein expression, and microtentacle (McTN) formation, using multiple cancer …
gr, us, fr (code pays fourni par la source)